Christophe Pierre Weber - 18 Mar 2026 Form 3 Insider Report for TAKEDA PHARMACEUTICAL CO LTD (TAK)

Role
President and CEO, Director
Signature
/s/ Max Heuer, by power of attorney, for Christophe Weber
Issuer symbol
TAK
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 06:11:52 UTC
Previous filing
04 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Weber Christophe Pierre President and CEO, Director 2-1-1 NIHONBASHI-HONCHO, CHUO-KU, TOKYO, JAPAN /s/ Max Heuer, by power of attorney, for Christophe Weber 18 Mar 2026 0002011270

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TAK Ordinary Shares 935,300 18 Mar 2026 Direct F1
holding TAK American Depositary Shares 253,433 18 Mar 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TAK Tax Obligation Award 18 Mar 2026 Ordinary Shares 46,367 Direct F3
holding TAK Tax Obligation Award 18 Mar 2026 Ordinary Shares 32,966 Direct F3
holding TAK Tax Obligation Award 18 Mar 2026 Ordinary Shares 17,296 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 96,000 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Ordinary Share. The RSUs vest on the following schedule: June 1, 2026 (46,100 shares), June 1, 2027 (32,700 shares) and June 1, 2028 (17,200 shares).
F2 Includes 204,008 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest on the following schedule: July 1, 2026 (95,744 shares), July 1, 2027 (72,384 shares) and July 1, 2028 (35,850 shares).
F3 Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.

Remarks:

Exhibit 24 Power of Attorney